Does CYP3A5 polymorphism influence everolimus intestinal and hepatic metabolism?

被引：0
|
作者：
Rouguieg-Malki, K.
Picard, N.
Marquet, P.
机构：
[1] Univ Limoges, UMR S 850, INSERM, Limoges, France
[2] CHU Limoges, Limoges, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
346
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] In vitro metabolism of cyclosporine A by human kidney CYP3A5
    Dai, Y
    Iwanaga, K
    Lin, YS
    Hebert, MF
    Davis, CL
    Huang, WL
    Kharasch, ED
    Thummel, KE
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) : 1889 - 1902
  • [42] A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system
    Lee, Su-Jun
    van der Heiden, Ilse P.
    Goldstein, Joyce A.
    van Schaik, Ron H. N.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) : 67 - 71
  • [43] CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression
    Pasari, Amit S.
    Balwani, Manish R.
    Gurjar, Prasad
    Bawankule, Charulata
    Bhawane, Amol
    Tolani, Priyanka
    Kashiv, Pranjal
    Dubey, Shubham
    Katekhaye, Vijay M.
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (05) : 1305 - 1309
  • [44] Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro
    Dai, Y
    Hebert, MF
    Isoherranen, N
    Davis, CL
    Marsh, C
    Shen, DD
    Thummel, KE
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (05) : 836 - 847
  • [45] CYP3A5 polymorphism in kidney transplantation: individualizing tacrolimus dosing
    Pasari, Amit S.
    Balwani, Manish R.
    Bawankule, Charulata
    Sejpal, Kapil
    Gurjar, Prasad
    Kashiv, Pranjal
    Dubey, Shubham
    Malde, Sunny
    Gupta, Sushrut
    Pawar, Twinkle
    TRANSPLANTATION, 2024, 108 (09) : 170 - 170
  • [46] CYP3A5 Polymorphism in Renal Transplantation: A Key To Personalized Medicine
    Gurjar, Prasad
    Pasari, Amit
    Bhawane, Amol
    Tolani, Priyanka
    Kolte, Sanjay
    Katekhaye, Vijay
    Balwani, Manish
    TRANSPLANTATION, 2022, 106 (09) : S160 - S160
  • [47] Pharmacogenetics of Immunosuppressant Polymorphism of CYP3A5 in Renal Transplant Recipients
    Larriba, J.
    Imperiali, N.
    Groppa, R.
    Giordani, C.
    Algranatti, S.
    Redal, M. A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (01) : 257 - 259
  • [48] Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the CYP3A5*3 polymorphism
    Miyata-Nozaka, Y.
    Zain, S. Mohd
    Taguchi, M.
    Shigeyama, M.
    Isobe, T.
    Hanioka, N.
    PHARMAZIE, 2017, 72 (12): : 747 - 750
  • [49] Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: Differential metabolism by CYP3A4 and CYP3A5
    Cook, CS
    Berry, LM
    Kim, DH
    Burton, EG
    Hribar, JD
    Zhang, LM
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1344 - 1351
  • [50] CYP3A5 genotype does not influence the blood concentration of tacrolimus measured with the Abbott immunoassay
    Moreton, M
    Fredericks, S
    McKeown, DA
    Shiferaw, EW
    MacPhee, LAM
    Johnston, A
    Holt, DW
    CLINICAL CHEMISTRY, 2005, 51 (11) : 2214 - 2215
12345